Yves Guyon-Gellin

Apomine, a Novel Hypocholesterolemic Agent, Accelerates Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase and Stimulates Low Density Lipoprotein Receptor Activity*

C. Ammon-Zufferey, D. Masson, E. Niesor, 2004, Journal of Biological Chemistry.

Hypocholesterolaemic and Antiatherosclerotic Effects of Tetra-iso-propyl 2-(3,5-Di-tert-butyl-4-hydroxyphenyl)ethyl-1, 1-diphosphonate (SR-9223i)

K. Suckling, E. Niesor, W. Kerns, 2000, Arzneimittelforschung.

Apomine™, an inhibitor of HMG‐CoA‐reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo

P. Croucher, R. Russell, K. Vanderkerken, 2007, International journal of cancer.